Articles by 황유미
황유미
-
SK Telecom’s venture startup bags US$10m contract
[THE INVESTOR] SK Telecom announced on Sept. 27 that its venture affiliate Cremotech has signed a US$10 million contract with US distribution company KDC to supply stick-type smart beam laser projectors.Since 2013, the country’s largest wireless telecommunications company has supported the startup making 2.58 billion won (US$2.32 million) equity investment and providing nine patented technologies for free.They jointly succeeded in developing the world’s first handheld projector based on laser as
Sept. 27, 2016
-
China’s Lancy to set up W164b JV with KEB Hana Bank
[THE INVESTOR] Chinese apparel company Lancy Group has decided to jointly establish an asset management firm with KEB Hana Bank, according to local media outlet edaily on Sept. 27.The joint venture with an estimated 1 billion yuan (US$149.70 million) initial equity capital will first invest in medical cosmetics. Lancy Group has acquired 30 percent stake in South Korea’s Dream Medical Group that consists of multiple hospitals and clinics related to aesthetics and cosmetic procedures for 4.5 billi
Sept. 27, 2016
-
Ahngook Pharm to adopt Y Biologics’ cancer immune treatment
[THE INVESTOR] Ahngook Pharm has signed an agreement to adopt Y Biogologics’ immune checkpoint inhibitor, it announced on Sept. 27.The pharmaceutical company will run non-clinical and clinical trials on the antibody that restores or enhances the immune system’s ability to fight cancer. The treatment has been reported to have less side effects than first generation chemical therapy that attacks normal tissues and to be more effective than the second generation targeted therapy that kills or deter
Sept. 27, 2016
-
Kolmar, Cosmax top global cosmetics ODM market
[THE INVESTOR] South Korean cosmetics original development manufacturers Kolmar Korea and Cosmax are further solidifying their top positions, continuing double digit growth and expanding overseas.Kolmar and its subsidiaries reported 616.1 billion won (US$554.90 million) revenue in cosmetics business in 2015, according to Financial Supervisory Service’s data on Sept. 26. Cosmax’s six affiliates have posted a combined 592.6 billion won sales last year. Intercos of Italy, which has dominated the gl
Sept. 27, 2016
-
Doosan Heavy denies selling stake in Doosan Engine
[DISCLOSURE] Doosan Heavy Industries (034020) denied media reports that it plans to sell its stake in Doosan Engine (082740), in a statement released on Sept. 26 in response to Korea Exchange’s inquiry. (theinvestor@heraldcorp.com)
Sept. 27, 2016
-
KT acquires N Search Marketing for W60b
[THE INVESTOR] KT and its digital media representative Nasmedia announced on Sept. 26 that they will take over top search advertising firm N Search Marketing for 60 billion won (US$54.38 million).The country’s largest telecom and internet group will own 33.3 percent stake and its affiliate will own the rest. N Search Marketing is a leading online advertising agency whose clients include Google, Facebook and Naver. It split off from Naver, and since 2014 has been owned by Han & Co. With this merg
Sept. 26, 2016
-
Seegene to supply 7.5m euros diagnosis kits to Italian state hospitals
[THE INVESTOR] Seegene announced on Sept. 26 that its Italian subsidiary Arrow Diagnostics has signed a five-year contract to supply sexually transmitted diseases and human papillomavirus detectors worth 7.5 million euros (US$8.43 million) to 17 state hospitals in Italy’s Toscana region. The South Korean company will provide molecular testers that can simultaneously test multiple sexually transmitted infections (AnyplexII STI-7) and multiple genotypes of human papillomavirus (AnyplexII HPV28) wi
Sept. 26, 2016
-
Boyrung Pharma’s hypertensive drug to be sold in Russia, Southeast Asia
[THE INVESTOR] Boryung Pharmaceutical announced on Sept. 26 that its high blood pressure treatment Kanarb is close to being approved for sale in Russia, Singapore and Malaysia.“Kanarb is expected to be granted permission in Russia in October, and in Singapore and Malaysia within this year. The official launch will be in the first half of 2017,” said Choi Seong-won, head of global business at the South Korean pharmaceutical company at a press conference in Seoul. The firm has partnered with Russi
Sept. 26, 2016
-
Ildong Pharma to launch new Hepatitis B drug next year
[THE INVESTOR] Ildong Pharmaceutical’s Hepatitis B treatment Besifovir is in the process of receiving the Ministry of Food and Drug Safety’s approval for sales, according to industry sources on Sept. 26. It will be the first new drug to be developed by the South Korea pharmaceutical company, to be introduced next year.Besifovir has completed phase 3 of clinical trials that found it to be as effective as Gilead Science’s Viread, which sold more than 100 billion won (US$90.63 million) worldwide in
Sept. 26, 2016
-
DSME to sell HQ to Capstone for W170b
[THE INVESTOR] Daewoo Shipbuilding and Marine Engineering will sell its Seoul headquarters building to Capstone Asset Management for 170 billion won (US$154.07 million), according to news reports on Sept. 26. This is 5 billion won less than the price suggested by KORAMCO, which has been selected as the exclusive negotiation partner for the sale of the 22-story building, with 24,854 square meter gross area. DSME abruptly halted talks with the real estate developer last week when the company faile
Sept. 26, 2016
-
Two suitors vie for Suwan Energy acquisition
[THE INVESTOR] Two suitors have participated in the bid to acquire Suwan Energy, according to the Seoul Central District Court on Sept. 23.“Two companies have turned in letters of intent,” said a source at the bankruptcy department of the court adding that “a preferred bidder will be chosen next week.”The sale of South Jeolla Province-based heat and power plant operator will be used to pay off the 106 billion won (US$95.91 million) debt of its parent company Keangnam Enterprises which owns 70 pe
Sept. 23, 2016
-
Firstec to assemble, sell UVision’s smart UAV
[THE INVESTOR] Firstec has signed a memorandum of understanding with Israel’s UVision on Sept. 16 to develop South Korea’s first smart unmanned aerial vehicle that incorporates a guided missile. The homegrown aviation defense company will take charge of manufacturing and assembling parts and exclusively sell the short-range lethal aerial loitering system of UVision, which was the first to commercialize the weapon. “South Korea is a strategic market for us for two main reasons. First, we have ide
Sept. 23, 2016
-
KEPCO, subsidiaries to invest W8b in new energy
[THE INVESTOR] Korea Electric Power Corp. decided to invest 8.3 trillion won (US$7.51 billion) in new energy businesses such as energy storage system by 2020, at a meeting with its subsidiaries in Seoul on Sept. 23.The state-owned utility firm will also increase the budget for research and development in the field to 700 billion won by 2025 from the current 100 billion won. KEPCO also confirmed that it will invest over 10 trillion won to implement government plans for closing down power plants a
Sept. 23, 2016
-
Kyung Dong to build W13b boiler factory in Beijing
[THE INVESTOR] Kyung Dong Navien is building a boiler and water heater factory in Beijing, it announced on Sept. 23. The boiler company is investing 13 billion won (US$11.76 million) for an automated facility that can manufacture up to 300,000 units a year by 2017, and will expand and complete the plant with a capacity for 500,000 by 2020.It was the first South Korean boiler maker to enter China in 1993. The leading energy company made 48 percent of its 512 billion won annual sales in overseas m
Sept. 23, 2016
-
More than 10 bio plants to be built in Korea by 2020
[THE INVESTOR] About 10 bio plants are scheduled to start operating by 2020, according to news reports on Sept. 22. Four plants including those of pharmaceutical heavyweights Daewoong and Green Cross, both in North Chungcheong Province, will be completed later this year. SK Plasma’s factory for blood derivatives as well as SK Biotech’s plant are slated to open in 2017 while mega biosimilar facilities of Samsung Biologics and Celltrion will operate from 2018 in Incheon. A screen welcoming visitor
Sept. 23, 2016
Most Popular
-
1
Dongduk Women’s University halts coeducation talks
-
2
Defense ministry denies special treatment for BTS’ V amid phone use allegations
-
3
Russia sent 'anti-air' missiles to Pyongyang, Yoon's aide says
-
4
OpenAI in talks with Samsung to power AI features, report says
-
5
Two jailed for forcing disabled teens into prostitution
-
6
Trump picks ex-N. Korea policy official as his principal deputy national security adviser
-
7
South Korean military plans to launch new division for future warfare
-
8
Gold bars and cash bundles; authorities confiscate millions from tax dodgers
-
9
Kia EV9 GT marks world debut at LA Motor Show
-
10
Teen smoking, drinking decline, while mental health, dietary habits worsen